NPASS Compound

Structure

NPC489152 OpenBabel06302215122D 33 38 0 0 1 0 0 0 0 0999 V2000 3.0325 1.3978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0331 0.3886 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 3.5382 -0.4852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5290 -0.4857 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 2.5295 -1.4591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6868 -1.9463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8435 -1.4601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8430 -0.4867 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.0254 -0.9887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6857 0.0005 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.6854 0.9744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8424 1.4611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0003 0.9739 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.0006 1.9770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8439 1.4606 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.8441 2.4339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6877 2.9206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5310 2.4334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5307 1.4601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2165 1.4596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.9255 0.7501 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.2167 2.4329 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.3746 2.9201 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -3.3752 3.9232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6872 0.9734 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -2.5557 0.4716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6869 -0.0005 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.8433 -0.4872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.0000 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -2.5302 -0.4877 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.5299 -1.4615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3732 -1.9487 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.6864 -1.9483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 1 0 0 0 2 3 1 0 0 0 0 2 4 1 0 0 0 0 4 3 1 6 0 0 0 4 10 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 8 29 1 0 0 0 0 8 9 1 1 0 0 0 8 10 1 0 0 0 0 10 11 1 1 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 13 29 1 0 0 0 0 13 14 1 1 0 0 0 13 15 1 0 0 0 0 15 16 1 1 0 0 0 15 25 1 0 0 0 0 16 17 1 0 0 0 0 17 18 1 0 0 0 0 18 23 1 0 0 0 0 18 19 2 0 0 0 0 19 20 1 0 0 0 0 19 25 1 0 0 0 0 20 21 2 0 0 0 0 20 22 1 0 0 0 0 22 23 1 0 0 0 0 23 24 1 1 0 0 0 25 26 1 1 0 0 0 25 27 1 0 0 0 0 27 28 1 0 0 0 0 27 30 1 6 0 0 0 29 28 1 1 0 0 0 30 31 1 0 0 0 0 31 32 2 0 0 0 0 31 33 1 0 0 0 0 M END $$$$

Physi-Chem Properties

Molecular Weight:	108.07
Volume:	117.86
LogP:	0.593
LogD:	0.687
LogS:	0.785
# Rotatable Bonds:	0
TPSA:	25.78
# H-Bond Aceptor:	2
# H-Bond Donor:	0
# Rings:	1
# Heavy Atoms:	2

MedChem Properties

QED Drug-Likeness Score:	0.497
Synthetic Accessibility Score:	2.354
Fsp3:	0.333
Lipinski Rule-of-5:	Accepted
Pfizer Rule:	Accepted
GSK Rule:	Accepted
BMS Rule:	0
Golden Triangle Rule:	Rejected
Chelating Alert:	0
PAINS Alert:	0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:	-4.486
MDCK Permeability:	2.5421793907298706e-05
Pgp-inhibitor:	0.0
Pgp-substrate:	0.006
Human Intestinal Absorption (HIA):	0.003
20% Bioavailability (F20%):	0.004
30% Bioavailability (F30%):	0.004

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):	0.604
Plasma Protein Binding (PPB):	42.56034851074219%
Volume Distribution (VD):	1.22
Pgp-substrate:	66.03377532958984%

ADMET: Metabolism

CYP1A2-inhibitor:	0.493
CYP1A2-substrate:	0.799
CYP2C19-inhibitor:	0.05
CYP2C19-substrate:	0.762
CYP2C9-inhibitor:	0.008
CYP2C9-substrate:	0.209
CYP2D6-inhibitor:	0.011
CYP2D6-substrate:	0.678
CYP3A4-inhibitor:	0.091
CYP3A4-substrate:	0.435

ADMET: Excretion

Clearance (CL):	9.329
Half-life (T1/2):	0.603

ADMET: Toxicity

hERG Blockers:	0.026
Human Hepatotoxicity (H-HT):	0.492
Drug-inuced Liver Injury (DILI):	0.38
AMES Toxicity:	0.007
Rat Oral Acute Toxicity:	0.788
Maximum Recommended Daily Dose:	0.033
Skin Sensitization:	0.93
Carcinogencity:	0.343
Eye Corrosion:	0.924
Eye Irritation:	0.982
Respiratory Toxicity:	0.977

Download Data

Data Type	Select
General Info & Identifiers & Properties
Structure MOL file
Source Organisms
Biological Activities
Similar NPs/Drugs

Natural Product: NPC489152

Natural Product ID:	NPC489152
*Common Name:**	IHGSXUAIUZAWKH-DGUHDFOTSA-N
IUPAC Name:	n.a.
Synonyms:
Standard InCHIKey:	IHGSXUAIUZAWKH-DGUHDFOTSA-N
Standard InCHI:	InChI=1S/C29H42O4/c1-16-15-29(16)12-7-11-26(4)21(29)10-13-27(5)20-9-8-19-17(2)32-25(31)24(19)28(20,6)23(14-22(26)27)33-18(3)30/h16-17,20-23H,7-15H2,1-6H3/t16-,17-,20-,21+,22+,23-,26-,27-,28+,29-/m0/s1
SMILES:	C[C@H]1C[C@]21CCC[C@@]1(C)[C@H]2CC[C@@]2(C)[C@@H]3CCC4=C(C(=O)O[C@H]4C)[C@@]3(C)[C@H](C[C@H]12)OC(=O)C
Synthetic Gene Cluster:	n.a.
ChEMBL Identifier:	n.a.
PubChem CID:	n.a.
Chemical Classification:**	CHEMONTID:0000000 [Organic compounds] [CHEMONTID:0000012] Lipids and lipid-like molecules [CHEMONTID:0000259] Prenol lipids [CHEMONTID:0001552] Sesterterpenoids [CHEMONTID:0002883] Scalarane sesterterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

Species Source

Organism ID	Organism Name	Taxonomy Level	Family	SuperKingdom	Isolation Part	Collection Location	Collection Time	Reference
NPO19028	Dysidea granulosa	Species	n.a.	n.a.	n.a.	n.a.	n.a.	PMID[25863431]
NPO19028	Dysidea granulosa	Species	n.a.	n.a.	n.a.	n.a.	n.a.	PMID[27399938]
NPO19028	Dysidea granulosa	Species	n.a.	n.a.	n.a.	n.a.	n.a.	PMID[31990554]
NPO19028	Dysidea granulosa	Species	n.a.	n.a.	n.a.	n.a.	n.a.	Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

NP Quantity Composition/Concentration

Organism ID	NP ID	Organism Material Preparation	Organism Part	NP Quantity (Standard)	NP Quantity (Minimum)	NP Quantity (Maximum)	Quantity Unit	Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

Biological Activity

Activity Type	# Activity
GI50	5

Activity Type	# Activity
Cell Line	5

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference
NPT393	Cell Line	HCT-116	Homo sapiens	GI50	>	30000.0	nM	PMID[31990554]
NPT81	Cell Line	A549	Homo sapiens	GI50	>	30000.0	nM	PMID[31990554]
NPT181	Cell Line	Bel-7402	Homo sapiens	GI50	>	30000.0	nM	PMID[31990554]
NPT15	Cell Line	Jurkat	Homo sapiens	GI50	>	30000.0	nM	PMID[31990554]
NPT111	Cell Line	K562	Homo sapiens	GI50	>	30000.0	nM	PMID[31990554]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

● The left chart: Distribution of similarity level between NPC489152 and all remaining natural products in the NPASS database.
● The right table: Most similar natural products (Tc>=0.56 or Top200).

range	Tanimoto Coefficient
0-0.1	266
0.1-0.2	1747
0.2-0.3	5304
0.3-0.4	12689
0.4-0.5	9462
0.5-0.6	6735
0.6-0.7	5125
0.7-0.8	1320
0.8-0.85	32
0.85-0.9	6
0.9-0.95	8
0.95-1	3

Similarity Score	Similarity Level	Natural Product ID

Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

● The left chart: Distribution of similarity level between NPC489152 and all drugs/candidates.
● The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

range	Tanimoto Coefficient
0-0.1	232
0.1-0.2	1988
0.2-0.3	3839
0.3-0.4	2083
0.4-0.5	631
0.5-0.6	211
0.6-0.7	138
0.7-0.8	27
0.8-0.85	1
0.85-0.9	0
0.9-0.95	0
0.95-1	0

Similarity Score	Similarity Level	Drug ID	Developmental Stage

Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity

B: biological targets similarity

C: networks similarity

D: cell-based bioactivity similarity

E: similarity based on clinical data